Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dialysate Bicarbonate Prescription on Serum Calcification Propensity and Calciprotein Particles in Hemodialysis Patients

NCT06084858 is registered in ClinicalTrials.gov with Prim. Priv. Doz. Dr. Daniel Cejka as lead sponsor.

NCT NCT06084858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06084858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dialysate Bicarbonate Prescription on Serum Calcification Propensity and Calciprotein Particles in Hemodialysis Patients
Lead sponsor
Prim. Priv. Doz. Dr. Daniel Cejka
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2023
Completion date
August 1, 2024
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease